Your browser doesn't support javascript.
loading
Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis.
You, Jun; Han, Yuwen; Qiao, Haifeng; Han, Yun; Lu, Xiaoyan; Lu, Yiling; Wang, Xiaoyu; Kai, Haili; Zheng, Yanli.
Afiliação
  • You J; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong 226001, China.
  • Han Y; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong 226001, China.
  • Qiao H; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong 226001, China.
  • Han Y; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong 226001, China.
  • Lu X; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong 226001, China.
  • Lu Y; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong 226001, China.
  • Wang X; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong 226001, China.
  • Kai H; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong 226001, China.
  • Zheng Y; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong 226001, China.
Aging (Albany NY) ; 14(11): 4699-4713, 2022 06 10.
Article em En | MEDLINE | ID: mdl-35687899

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / MicroRNAs Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / MicroRNAs Idioma: En Ano de publicação: 2022 Tipo de documento: Article